Pro12Ala polymorphism of the peroxisome proliferator-activated receptor &gamma;2 in patients with fatty liver diseases

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

421

HTML

4178

Figures (1-3)

186

Tables (1-6)

172

Sum=4957

Dec 14, 2010 (publication date) through Jul 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 14, 2010; 16(46): 5830-5837
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5830

Table 4 Histological features in the fatty liver diseases cohort

Cases of fatty liver disease (n = 363)	n (%)
Steatosis
S0	9 (2.5)
S1	169 (46.6)
S2	84 (23.1)
S3	101 (27.8)
Ballooning
No ballooning	164 (45.2)
Stage 1	124 (34.2)
Stage 2	75 (20.7)
Inflammation
G0	4 (1.1)
G1	217 (59.8)
G2	113 (31.1)
G3	29 (8)
Fibrosis
F0	97 (26.7)
F1	116 (32)
F2	66 (18.2)
F3	56 (15.4)
F4	28 (7.7)

Citation: Rey JW, Noetel A, Hardt A, Canbay A, Alakus H, Hausen AZ, Dienes HP, Drebber U, Odenthal M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. World J Gastroenterol 2010; 16(46): 5830-5837
URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5830.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i46.5830